91 related articles for article (PubMed ID: 1854962)
21. Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs.
Markov AK; Payment MF; Hume AS; Rao MR; Markov MA; Skelton TN; Lehan PH
Vet Hum Toxicol; 1999 Feb; 41(1):9-15. PubMed ID: 9949476
[TBL] [Abstract][Full Text] [Related]
22. [Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
Pasotti C; Nicrosini S; Fiori G
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):315-20. PubMed ID: 2640054
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
Kostin VI; Iakushev MP; Sapozhkov AV
Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations.
Markov AK
Ann Emerg Med; 1986 Dec; 15(12):1470-7. PubMed ID: 3777620
[TBL] [Abstract][Full Text] [Related]
25. The effects of fructose-1,6-diphosphate on the isolated rabbit heart.
Pfaffman MA; Terry J; Grillis M; Markov A
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):211-26. PubMed ID: 6635317
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock.
Zhang JN; Zhang FM; Ma WS; Forrester T
Cardiovasc Res; 1988 Dec; 22(12):927-32. PubMed ID: 3256432
[TBL] [Abstract][Full Text] [Related]
27. Effects of nimodipine and fructose-1,6-diphosphate on cerebral damage in carbon monoxide poisoning mice.
Yang J; Zhao X; Zhou Q; Jiang Q
Chin Med J (Engl); 2003 Dec; 116(12):1911-5. PubMed ID: 14687483
[TBL] [Abstract][Full Text] [Related]
28. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model.
Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG
J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990
[TBL] [Abstract][Full Text] [Related]
29. [Protective effect of 1,6-diphosphate fructose in ischemic renal failure in elderly rats].
Li LY; Wang HY; Shi JH
Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):9-12, 61. PubMed ID: 8032987
[TBL] [Abstract][Full Text] [Related]
30. [Glycerinated myocardiocyte fibers in the rat myocardium as one of the models in a preclinical assessment of antianginal agents].
Dzhanpoladian EG; Sambelian VM; Kaĭfadzhian MA; Tatinian NG; Khoetsian EL
Biull Eksp Biol Med; 1989 Apr; 107(4):444-6. PubMed ID: 2720162
[TBL] [Abstract][Full Text] [Related]
31. Endothelium and myocyte cellular insulin receptor alterations in a rat model of myocardial infarction.
Jaroudi WA; Jurjus AR; El-Sabban ME; Kamal MT; Bitar KM; Bikhazi AB
Can J Physiol Pharmacol; 2003 Mar; 81(3):267-73. PubMed ID: 12733825
[TBL] [Abstract][Full Text] [Related]
32. [Protective effects of fructose-1,6-diphosphate on brain damage caused by febrile seizures in rats].
Zhou JP; Wang F; Li RL; Yuan BL; Li J; Xu ED
Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):129-33. PubMed ID: 15059490
[TBL] [Abstract][Full Text] [Related]
33. A comparison between fructose 1,6-diphosphate, glucose, or normal saline infusions and species-specific blood exchange transfusions in the treatment of bowel ischemia.
Sawchuk A; Canal D; Slaughter M; Bearman D; O'Connor T; Grosfeld JL
Surgery; 1986 Oct; 100(4):665-70. PubMed ID: 3764691
[TBL] [Abstract][Full Text] [Related]
34. [Effect of fructose-1,6-diphosphate on the size of the necrotic area and course of the acute period of experimental myocardial infarction in rats].
Sernov LN; Snegireva GV; Gatsura VV
Kardiologiia; 1989 Aug; 29(8):66-9. PubMed ID: 2585964
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
Stets VR; Tishkin VS; Evdokimov EI
Vrach Delo; 1989 Dec; (12):13-4. PubMed ID: 2483471
[TBL] [Abstract][Full Text] [Related]
36. [The protective effect of 17 beta-estradiol in experimental myocardial infarct].
Mambetova AZh; Matiushin AI; Shimanovskiĭ NL; Karachentsev AN
Eksp Klin Farmakol; 1996; 59(2):15-6. PubMed ID: 8974555
[TBL] [Abstract][Full Text] [Related]
37. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
Luk'ianova LO; Kudrin AN; Kogan AKh
Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
[TBL] [Abstract][Full Text] [Related]
38. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
Pagel PS; Krolikowski JG
Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
[TBL] [Abstract][Full Text] [Related]
39. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of action of beta-adrenoblockaders in ischemic heart disease].
Likhtenshteĭn IE; Evstratova IN; Il'iash MG
Vrach Delo; 1986 Aug; (8):14-6. PubMed ID: 2877525
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
